Chemical Works of Gedeon Richter Plc (RGEDF)
39.30
-0.84
(-2.08%)
USD |
OTCM |
Sep 15, 16:00
Chemical Works of Gedeon Richter Market Cap : 7.195B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 7.195B |
| September 14, 2026 | 7.348B |
| September 11, 2026 | 7.212B |
| September 10, 2026 | 7.499B |
| September 09, 2026 | 7.441B |
| September 08, 2026 | 7.443B |
| September 04, 2026 | 7.576B |
| September 03, 2026 | 7.362B |
| September 02, 2026 | 7.460B |
| September 01, 2026 | 7.722B |
| August 31, 2026 | 7.727B |
| August 28, 2026 | 7.918B |
| August 27, 2026 | 7.918B |
| August 26, 2026 | 7.955B |
| August 25, 2026 | 8.012B |
| August 24, 2026 | 7.929B |
| August 21, 2026 | 7.654B |
| August 20, 2026 | 7.654B |
| August 19, 2026 | 7.781B |
| August 18, 2026 | 7.638B |
| August 17, 2026 | 7.695B |
| August 14, 2026 | 7.797B |
| August 13, 2026 | 7.598B |
| August 12, 2026 | 7.701B |
| August 11, 2026 | 7.594B |
| Date | Value |
|---|---|
| August 10, 2026 | 7.347B |
| August 07, 2026 | 7.278B |
| August 06, 2026 | 6.959B |
| August 05, 2026 | 7.466B |
| August 04, 2026 | 7.020B |
| August 03, 2026 | 6.955B |
| July 31, 2026 | 6.941B |
| July 30, 2026 | 6.929B |
| July 29, 2026 | 6.791B |
| July 28, 2026 | 6.884B |
| July 27, 2026 | 6.783B |
| July 24, 2026 | 6.771B |
| July 23, 2026 | 6.772B |
| July 22, 2026 | 6.684B |
| July 21, 2026 | 7.012B |
| July 20, 2026 | 7.012B |
| July 17, 2026 | 7.061B |
| July 16, 2026 | 7.063B |
| July 15, 2026 | 6.949B |
| July 14, 2026 | 7.131B |
| July 13, 2026 | 6.956B |
| July 10, 2026 | 7.173B |
| July 09, 2026 | 6.952B |
| July 08, 2026 | 7.160B |
| July 07, 2026 | 7.160B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 507.22B |
| ANI Pharmaceuticals, Inc. | 1.679B |
| Corcept Therapeutics, Inc. | 12.16B |
| Veru, Inc. | 40.24M |
| Avadel Pharmaceuticals Plc | 2.104B |
Market Cap Related Metrics
| PE Ratio | 10.92 |
| PS Ratio | 2.538 |
| PEG Ratio | 1.006 |
| Price to Book Value | 1.648 |
| Price to Free Cash Flow | 8.898 |
| Price | 39.30 |
| Earnings Yield | 9.16% |
| PEGY Ratio | 0.6694 |
| Operating PE Ratio | 7.164 |
| Normalized PE Ratio | 10.92 |